EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Degenerative Mitral Regurgitation: From Prolapse to Precision Therapy

Joanna Chikwe iD, Francesca N Delling iD, Annetine C Gelijns

Circulation · 17.11.2026 · 154 (20) · 2052-2063

DOI: 10.1161/circulationaha.126.081203 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Circulation, erschienen am 17.11.2026. Verfasst von Joanna Chikwe und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Surgery, Cedars Sinai Health Sciences University, Los Angeles, CA (J.C.). Hauptthemen laut MEDLINE: Mitral Valve Insufficiency, Mitral Valve Prolapse, Precision Medicine. Die Arbeit nennt 58 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Degenerative mitral valve regurgitation due to mitral valve prolapse affects ≈15 million people globally and is the commonest indication for mitral intervention in high-income countries, but its biology, natural history, and lifetime management are ill defined. This review summarizes current knowledge of the epidemiology, pathophysiology, diagnosis, risk stratification, and lifetime management of degenerative mitral regurgitation, with a focus on areas of uncertainty, recent advances, and emerging research directions. These include translational research focused on determining genetic and cellular drivers of disease progression and mechanistic studies geared to improve detection and prevention of downstream myocardial dysfunction, particularly in high-risk phenotypes, including arrhythmic mitral prolapse. The current landscape of randomized trials and large registries comparing contemporary surgical and transcatheter treatment and strategies to improve patient access to care and outcomes across all patient risk profiles and populations are also discussed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mitral Valve InsufficiencyMitral Valve ProlapsePrecision MedicineHumansAnimals

Stichwörter der Autor:innen

echocardiographymitral valve insufficiencymitral valve prolapsemitral valve, surgerytranscatheter cardiovascular interventionsventricular remodeling

Autor:innen und Institutionen

  • Department of Cardiac Surgery, Cedars Sinai Health Sciences University, Los Angeles, CA (J.C.).
  • Division of Cardiology, Department of Medicine, University of California San Francisco (F.N.D.).
  • Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY (A.C.G.).

ORCID-Profile: Joanna Chikwe, Francesca N Delling

Zitieren

APA

Chikwe, J., Delling, F. N., & Gelijns, A. C. (2026). Degenerative Mitral Regurgitation: From Prolapse to Precision Therapy. Circulation, 154(20), 2052-2063. https://doi.org/10.1161/circulationaha.126.081203

Vancouver

Chikwe J, Delling FN, Gelijns AC. Degenerative Mitral Regurgitation: From Prolapse to Precision Therapy. Circulation. 2026;154(20):2052-2063. doi:10.1161/circulationaha.126.081203

BibTeX
@article{Chikwe2026,
  author = {Chikwe, Joanna and Delling, Francesca N and Gelijns, Annetine C},
  title = {Degenerative Mitral Regurgitation: From Prolapse to Precision Therapy},
  journal = {Circulation},
  year = {2026},
  volume = {154},
  number = {20},
  pages = {2052--2063},
  doi = {10.1161/circulationaha.126.081203}
}
Kostenlos starten →